11.25
0.09%
0.010
Dopo l'orario di chiusura:
11.25
Precedente Chiudi:
$11.24
Aprire:
$11.14
Volume 24 ore:
301.86K
Relative Volume:
0.57
Capitalizzazione di mercato:
$735.39M
Reddito:
$512.35M
Utile/perdita netta:
$-156.23M
Rapporto P/E:
-2.4563
EPS:
-4.58
Flusso di cassa netto:
$7.98M
1 W Prestazione:
-9.57%
1M Prestazione:
-13.13%
6M Prestazione:
+76.33%
1 anno Prestazione:
+193.73%
Bioventus Inc Stock (BVS) Company Profile
Nome
Bioventus Inc
Settore
Industria
Telefono
(919) 474-6700
Indirizzo
4721 EMPEROR BOULEVARD, SUITE 100, DURHAM
Confronta BVS con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
BVS | 11.25 | 735.39M | 512.35M | -156.23M | 7.98M | -4.58 |
ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Bioventus Inc Stock (BVS) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-08-09 | Aggiornamento | Craig Hallum | Hold → Buy |
2022-11-22 | Downgrade | Craig Hallum | Buy → Hold |
2022-11-09 | Downgrade | Canaccord Genuity | Buy → Hold |
2022-11-09 | Downgrade | JP Morgan | Overweight → Underweight |
2022-03-15 | Iniziato | Craig Hallum | Buy |
2021-11-15 | Ripresa | Morgan Stanley | Overweight |
2021-11-10 | Ripresa | JP Morgan | Overweight |
2021-07-01 | Downgrade | Goldman | Buy → Neutral |
2021-03-08 | Iniziato | Canaccord Genuity | Buy |
2021-03-08 | Iniziato | Goldman | Buy |
2021-03-08 | Iniziato | JP Morgan | Overweight |
2021-03-08 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Bioventus Inc Borsa (BVS) Ultime notizie
Royce & Associates LP Invests $8.34 Million in Bioventus Inc. (NYSE:BVS) - MarketBeat
Los Angeles Capital Management LLC Acquires Shares of 143,464 Bioventus Inc. (NYSE:BVS) - MarketBeat
Bioventus Inc (BVS) Stock Price Down 2.45% on Nov 12 - GuruFocus.com
Bioventus Inc. (NASDAQ:BVS) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Bioventus reports robust Q3 growth, raises full-year guidance - Investing.com India
Bioventus stock target upgraded, hold buy on strong Q3 performance - Investing.com
Where are the Opportunities in (BVS) - Stock Traders Daily
Bioventus stock target upgraded, hold buy on strong Q3 performance By Investing.com - Investing.com UK
Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Rev - GuruFocus.com
Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... - Yahoo Finance
Bioventus Reports Strong Revenue Growth in Q3 2024 - TipRanks
Bioventus (NYSE:BVS) Shares Gap DownShould You Sell? - MarketBeat
How Are Things Looking For Bioventus Inc (NASDAQ: BVS) For The Short Term? - Stocks Register
BVSBioventus Inc. Latest Stock News & Market Updates - StockTitan
Bioventus: Q3 Earnings Snapshot - San Francisco Chronicle
Bioventus (BVS) Matches Q3 Earnings Estimates - Yahoo Finance
Bioventus Inc Reports Q3 2024 Earnings: Revenue Hits $139 Millio - GuruFocus.com
Bioventus (NYSE:BVS) Releases FY24 Earnings Guidance - MarketBeat
Bioventus Reports Third Quarter Financial Results - The Manila Times
Bioventus reports Q3 adjusted EPS 6c, consensus 3c - TipRanks
Bioventus Inc. Revises Earnings Guidance for the Twelve Months Ending December 31, 2024 - Marketscreener.com
Are Medical Stocks Lagging Bioventus (BVS) This Year? - Yahoo Finance
Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Loo - GuruFocus.com
Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Bioventus stock soars to 52-week high, hits $13.65 - Investing.com India
Bioventus stock soars to 52-week high, hits $13.65 By Investing.com - Investing.com South Africa
Bioventus (BVS) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Should Bioventus Stock Be in Your Portfolio Pre-Q3 Earnings? - MSN
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024 - The Manila Times
Long Term Trading Analysis for (BVS) - Stock Traders Daily
Bioventus Surges 73% in Three Months: Time to Buy the Stock? - MSN
Bioventus (NYSE:BVS) Reaches New 1-Year HighStill a Buy? - MarketBeat
Bioventus stock soars to 52-week high, hits $13.14 - Investing.com India
SG Americas Securities LLC Lowers Stock Position in Bioventus Inc. (NYSE:BVS) - Defense World
Are Medical Stocks Lagging ChromaDex (CDXC) This Year? - Yahoo Finance
Bioventus stock soars to 52-week high of $12.43 amid growth By Investing.com - Investing.com South Africa
Bioventus (NYSE:BVS) Reaches New 52-Week HighStill a Buy? - MarketBeat
Bioventus stock soars to 52-week high of $12.43 amid growth - Investing.com Australia
Dimensional Fund Advisors LP Buys 58,954 Shares of Bioventus Inc. (NYSE:BVS) - MarketBeat
Bone Growth Products Global Market Report |Bioventus, Djo, Johnson & Johnson, Medtronic, Orthofix, Stryker, Zimmer Biome – IndiaPolitics.com - IndiaPolitics.com
Bioventus (NYSE:BVS) Trading Up 7.5%Here's What Happened - MarketBeat
Bioventus (NYSE:BVS) Shares Up 7.5%What's Next? - MarketBeat
Buying Buzz: Bioventus Inc [BVS] Director Bartholdson John A. acquires 80,000 shares of the company - Knox Daily
Ratio Revelations: Bioventus Inc (BVS)’s Financial Metrics in the Spotlight - The Dwinnex
Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Bank of Montreal Can Invests $774,000 in Bioventus Inc. (NYSE:BVS) - MarketBeat
Bioventus Inc Azioni (BVS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):